Nestle ups stake in food allergy drug developer
Nestle ’s health science arm will pay $98 million to raise its stake in Aimmune Therapeutics, as the drug developer prepares to submit a marketing application for its peanut allergy treatment before the end of the year.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: Allergy | Allergy & Immunology | Food Allergy | Marketing | Peanuts | Pharmaceuticals | Science